Qing‐Yu He

63.4k citations

397 papers · 39.0k indexed · 7 hit papers · h-index 56

Impact in

Cancer Research top 0.05%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 0.05%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing

Papers in

Molecular Biology 224
- RNA modifications and cancer 31
- Ubiquitin and proteasome pathways 21
- RNA and protein synthesis mechanisms 17
Molecular Medicine 15

Co-authors: Guangchuang Yu Yanyan Han Jen‐Fu Chiu Hongzhe Sun Chi‐Ming Che Chun‐Nam Lok Rong Chen Wing‐Yiu Yu
Journals: Journal of Proteome Research (26 papers)PROTEOMICS (24 papers)Biochemistry (12 papers)Biochemical Journal (11 papers)Journal of Proteomics (10 papers)
Partner nations: China Hong Kong United States

In The Last Decade

Qing‐Yu He

382 papers receiving 38.7k citations

Hit Papers

7 papers align trajectories log scale

Advances in targeted therapy for esophageal cancer 2020 · 324 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Signal Transduction and Targeted Therapy
2015 Bioinformatics
2015 Molecular BioSystems
2014 Bioinformatics
2012 OMICS A Journal of Integrative Biology
2007 JBIC Journal of Biological Inorganic Chemistry
2006 Journal of Proteome Research

Peers

Countries citing papers authored by Qing‐Yu He

Since Specialization

Citations

This map shows the geographic impact of Qing‐Yu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing‐Yu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing‐Yu He more than expected).

Fields of papers citing papers by Qing‐Yu He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing‐Yu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing‐Yu He. The network helps show where Qing‐Yu He may publish in the future.

Co-authors

The 25 scholars most cited alongside Qing‐Yu He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Qing‐Yu He Line = papers co-authored together Qing‐Yu He links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A new and more informative subtyping scheme for breast cancer based on co-expression of metabolic genes Genes & Diseases ·Shubhangi Mapare, Yuzhe Zhang, Jun Xiao, Qing‐Yu He, Wenyong Zhang, Ying Xu	2025	1
2	Novel bio-carriers for radionuclide delivery in cancer radiotherapy Coordination Chemistry Reviews ·M.J. Salkowski, Qing‐Yu He, 毕可然, Yan Gao, Guangming Zhou, Hongwei Si, Kai Yang, Lin Hu, Pei Pei	2025	5
3	Phase Current Based Fault Section Location for Single-Phase Grounding Fault in Non-Effectively Grounded Distribution Network IEEE Transactions on Industry Applications ·M. Weber, Qing‐Yu He, H. Termier, L. Halberstaedter, Tomáš Jurečka, Zhihua Zhang, Guobing Song	2025	0
4	The Antipsychotic Drug Aripiprazole Suppresses Colorectal Cancer by Targeting LAMP2a to Induce RNH1/miR‐99a/mTOR‐Mediated Autophagy and Apoptosis Advanced Science ·Huifang Hu, Yanli Zhao, Lei Han, S. Borel, Wei‐Xia Zhang, Chia Ming Wu, Nan Li, Gurichev Vv, Yifan Lu, Bae KiCheol, Yunlong Pan, Yang Wang, Qing‐Yu He	2024	4
5	Enhanced biodegradation of glyphosate by Chlorella sorokiniana engineered with exogenous purple acid phosphatase Water Research ·Si-Fen Liu, C.S. Matthews, Z. Huang, Z. Y. Yuan, B Kopeliovich, Yongteng Zhao, Qing‐Yu He, Wei‐Dong Yang, Hongye Li, Carol Sze Ki Lin, Xiang Wang	2024	8
6	Unveiling a novel mechanism for competitive advantage of ciprofloxacin-resistant bacteria in the environment through bacterial membrane vesicles Journal of Hazardous Materials ·Matthew Handy, Xinlu Zhao, Ziyuan Zhang, Jeremy Bowles, Jiliang Cheng, Piao Xia, Nan Li, Ruiguang Ge, Qing‐Yu He, Xuesong Sun	2024	5
7	Prediction of resilient modulus and critical dynamic stress of recycled aggregates: Experimental study and machine learning methods Transportation Geotechnics ·Yefei Wang, Yuanjie Xiao, V. F. Volkodavov, Qing‐Yu He, Yunbo Li, Wenqi Li	2024	7
8	Ynamide Electrophile for the Profiling of Ligandable Carboxyl Residues in Live Cells and the Development of New Covalent Inhibitors Journal of Medicinal Chemistry ·Shengrong Li, Pengwei Zhang, Fang Xu, Зарипов Вадим Маратович, Jia-Cong Liu, Yi Tan, Zhengchao Tu, Hongyan Sun, Zhimin Zhang, Qing‐Yu He, Pinghua Sun, Ke Ding, Zhengqiu Li	2022	25
9	Identification and Tetramer Structure of Hemin-Binding Protein SPD_0310 Linked to Iron Homeostasis and Virulence of Streptococcus pneumoniae mSystems ·Kun Cao, Tianlong Zhang, Nan Li, Xiao-Yan Yang, Jianping Ding, Qing‐Yu He, Xuesong Sun	2022	8
10	Crizotinib Shows Antibacterial Activity against Gram-Positive Bacteria by Reducing ATP Production and Targeting the CTP Synthase PyrG Microbiology Spectrum ·Isaac Antonio Garibay Sandoval, Mohannad Alheraki, Haiming Wu, Nan Li, Matthew Handy, Linlin Cao, Xingfeng Yin, Qing‐Yu He, Ruiguang Ge, Xuesong Sun	2022	14
11	SARS-CoV-2 Antibodies and Associated Factors at Different Hospitalization Time Points in 192 COVID-19 Cases The Journal of Applied Laboratory Medicine ·Jingyi Ou, Mingkai Tan, Zheng Zhou, Haiyan Tan, Hornecker Eva, Mennad Bounouir ILYAS ZAKARIA, Xiaowen Jiang, Qing‐Yu He, Ying Huang, Yan Li, П О Протопопова, A. Togni, Yaling Shi, Fang Li	2021	7
12	Autoactivation of Translation Causes the Bloom of Prorocentrum donghaiense in Harmful Algal Blooms Journal of Proteome Research ·Xin Cao, Zhong Guo, Hualong Wang, Yuelei Dong, Songhui Lü, Qing‐Yu He, Xuesong Sun, Gong Zhang	2021	2
13	Advances in targeted therapy for esophageal cancer Signal Transduction and Targeted Therapy ·Yuan‐Han Yang, (unknown), Wen Xu, Qing‐Yu He, Bin Li Hit paper breakdown →	2020	324
14	Holmium laser technologies versus photoselective greenlight vaporization for patients with benign prostatichyperplasia: a meta-analysis Lasers in Medical Science ·Liao Peng, Xiaonan Zheng, Carly Bronson, Xiao Zeng, Qing‐Yu He, Guo Chen, Tianhai Lin, Hong Shen, Deyi Luo	2020	3
15	A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients Theranostics ·温晓鹿, Qian Zhou, Lu Liu, 藤崎修兵, Weimin Ci, Wanting Liu, Gong Zhang, Zhiyi Zhang, Peng Wang, Aiqun Zhang, Yunfei Gao, Zou Men, Qing‐Yu He, Liang Chen	2019	16
16	The mechanism of iron-compensation for manganese deficiency of Streptococcus pneumoniae Journal of Proteomics ·Kun Cao, Nicolae Șofilca, Xinlu Zhao, Millah Fitriyah, A. N. Yasamanova, Ruiguang Ge, Qing‐Yu He, Xuesong Sun	2018	7
17	Synephrine Hydrochloride Suppresses Esophageal Cancer Tumor Growth and Metastatic Potential through Inhibition of Galectin-3-AKT/ERK Signaling Journal of Agricultural and Food Chemistry ·Wen Xu, Can‐Can Zheng, Solenne Zona, R. E. Larose, Adil Zaman, Francisco J. Calero-García, Yueming Wang, Qing‐Yu He, Hua‐Xin Liao, Bin Li	2018	28
18	Id1-Induced IGF-II and Its Autocrine/Endocrine Promotion of Esophageal Cancer Progression and Chemoresistance—Implications for IGF-II and IGF-IR–Targeted Therapy Clinical Cancer Research ·Bin Li, Sai Wah Tsao, Kwok Wah Chan, Dale L. Ludwig, Ruslan Novosyadlyy, L Zakariaee, Qing‐Yu He, Annie L.M. Cheung	2014	65
19	Phosphoproteome profile of human lung cancer cell line A549 Molecular BioSystems ·Guangchuang Yu, Chuan‐Le Xiao, Chunhua Lu, Vidhusha Srinivasan, Feng Ge, Wei Wang, Xingfeng Yin, Hong-Ling Jia, Jianxing He, Qing‐Yu He	2010	11
20	Expression and characterization of a histidine-rich protein, Hpn: potential for Ni2+ storage in Helicobacter pylori Biochemical Journal ·Ruiguang Ge, Rory M. Watt, Xuesong Sun, Julian A. Tanner, Qing‐Yu He, Jian‐Dong Huang, Hongzhe Sun	2005	87

About Qing‐Yu He

Qing‐Yu He is a scholar working on Molecular Biology, Molecular Medicine, Cancer Research, Hematology and Oncology, having authored 397 papers that have together received 39.0k indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (32 papers), RNA modifications and cancer (31 papers), Iron Metabolism and Disorders (25 papers), Ubiquitin and proteasome pathways (21 papers), Trace Elements in Health (20 papers), RNA and protein synthesis mechanisms (17 papers), Streptococcal Infections and Treatments (17 papers) and Cancer-related molecular mechanisms research (17 papers). The work is most often cited by research in Cancer Research (7.5k citations), Molecular Biology (21.6k citations), Immunology (5.3k citations), Oncology (5.3k citations) and Pulmonary and Respiratory Medicine (5.8k citations). Qing‐Yu He has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Guangchuang Yu, Yanyan Han, Jen‐Fu Chiu, Hongzhe Sun, Chi‐Ming Che, Chun‐Nam Lok, Rong Chen, Wing‐Yiu Yu, Xuesong Sun and Guang‐Rong Yan. Their work appears in journals such as Journal of Proteome Research, PROTEOMICS, Biochemistry, Biochemical Journal and Journal of Proteomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact